carbamazepine has been researched along with Affective Disorders in 96 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study prospectively examined whether continued add-on treatment with oxcarbazepine (OXC) is associated with quantitative improvement in mood and anxiety symptoms in adult patients with partial epilepsy." | 9.12 | Oxcarbazepine improves mood in patients with epilepsy. ( Bria, P; Della Marca, G; Di Nicola, M; Janiri, L; Martinotti, G; Mazza, M; Mazza, S; Pozzi, G, 2007) |
| "Lamotrigine is used in pregnancy to control epilepsy and mood disorders." | 8.95 | Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis. ( Adams-Webber, T; Barzilay, E; Leibson, T; Nulman, I; Pariente, G; Shulman, T, 2017) |
| " We review the clinical literature which suggests that tolerance can develop to most treatment approaches in bipolar illness and present an animal model of tolerance development to anticonvulsant effects of carbamazepine or lamotrigine on amgydala-kindled seizures." | 8.87 | Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders. ( Post, RM; Weiss, SR, 2011) |
| "Twenty-four patients suffering from affective disorders, who were being regularly treated with carbamazepine, were studied to determine the course of plasma levels of carbamazepine before (trough levels) and two and four hours after morning intake (peak levels)." | 7.67 | Measuring plasma levels of carbamazepine. A pharmacokinetic study in patients with affective disorders. ( Broekman, M; Jansen, GS; Nolen, WA, 1988) |
| " Since the effects of carbamazepine on substance P content are identical with previously described effects of lithium, an alteration in substance P neurotransmission may be one of the neurochemical bases of common clinical and behavioral effects of carbamazepine and lithium on affective disorders." | 7.67 | Effects of chronic treatment with trihexyphenidyl and carbamazepine alone or in combination with haloperidol on substance P content in rat brain: a possible implication of substance P in affective disorders. ( Mataga, N; Mitsushio, H; Takashima, M; Toru, M, 1988) |
| "A case of thrombocytopenia associated with carbamazepine use is reported, and previous reports of adverse hematologic effects in patients taking carbamazepine are discussed." | 7.67 | Thrombocytopenia associated with carbamazepine: case report and review. ( Baciewicz, G; Yerevanian, BI, 1984) |
| " According to the literature, OCBZ is regarded as effective in acute mania and appears to reduce the dosage of neuroleptics required for the treatment of affective and schizoaffective disorders." | 6.41 | Oxcarbazepine in affective and schizoaffective disorders. ( Dietrich, DE; Emrich, HM; Kropp, S, 2001) |
| "Affective disorders have a substantial public health impact due to morbidity, mortality, quality of life impairment and economic implications." | 6.41 | [Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness]. ( Ahrens, B; Becker, T; Roick, C, 2001) |
| "Treatment with carbamazepine was evaluated in an open study design in 29 gerontopsychiatric inpatients." | 5.29 | [Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients]. ( Lemke, MR; Stuhlmann, W, 1994) |
| "This study prospectively examined whether continued add-on treatment with oxcarbazepine (OXC) is associated with quantitative improvement in mood and anxiety symptoms in adult patients with partial epilepsy." | 5.12 | Oxcarbazepine improves mood in patients with epilepsy. ( Bria, P; Della Marca, G; Di Nicola, M; Janiri, L; Martinotti, G; Mazza, M; Mazza, S; Pozzi, G, 2007) |
| "Lamotrigine is used in pregnancy to control epilepsy and mood disorders." | 4.95 | Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis. ( Adams-Webber, T; Barzilay, E; Leibson, T; Nulman, I; Pariente, G; Shulman, T, 2017) |
| " We review the clinical literature which suggests that tolerance can develop to most treatment approaches in bipolar illness and present an animal model of tolerance development to anticonvulsant effects of carbamazepine or lamotrigine on amgydala-kindled seizures." | 4.87 | Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders. ( Post, RM; Weiss, SR, 2011) |
| "A systematic search was carried out of electronic databases, reference books and other sources for original research studies which examined the effects of commonly used mood stabilizers (sodium valproate, carbamazepine, lamotrigine and lithium carbonate) on pregnancy outcomes." | 4.86 | Mood stabilizers in pregnancy: a systematic review. ( Buist, A; Galbally, M; Roberts, M, 2010) |
| " As the result of the detailed analysis of the literature the author recommends lamotrigine, carbamazepine and oxcarbazepine as first choice antiepileptic drug for epileptic patients suffering from depressive disorder, too." | 4.84 | [Effects of antiepileptic drugs on mood of people with epilepsy]. ( Rajna, P, 2007) |
| "Controlled studies of lithium, valproate and carbamazepine in preventing future episodes of affective disorders were classified according to methodological rigour, and meta-analyses were performed overall and on each type." | 4.80 | Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis. ( Davis, JM; Hogan, DM; Janicak, PG, 1999) |
| "In an attempt to find the key to reducing the excessive morbidity and mortality seen with mood disorders, our laboratory has been extensively investigating lithium's mechanisms of action in an integrated series of clinical and preclinical studies." | 4.80 | Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. ( Bebchuk, JM; Chen, G; Glitz, D; Hasanat, KA; Manji, HK; Moore, GJ, 1999) |
| " We describe the phenomenon of amygdala-kindled seizures episodically breaking through effective daily pharmacotherapy with carbamazepine and valproate, suggesting that these observations could reflect the balance of pathological vs compensatory illness-induced changes in gene expression." | 4.79 | A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures. ( Post, RM; Weiss, SR, 1996) |
| " Preclinical data are presented that another primary pathological process--the occurrence of kindled seizures--can evoke endogenous compensatory processes that are either anticonvulsant in their own right, or enable the anticonvulsant effects of a drug such as carbamazepine." | 4.78 | Ziskind-Somerfeld Research Award 1992. Endogenous biochemical abnormalities in affective illness: therapeutic versus pathogenic. ( Post, RM; Weiss, SR, 1992) |
| "Patients with major affective disorders are more likely to complete suicide than patients in any other medical group." | 3.79 | Anticonvulsant therapy and suicide risk in affective disorders. ( Goodwin, FK, 1999) |
| " Addition of carbamazepine to lithium can counteract lithium-induced subclinical hypothyroidism, possibly improving prophylactic efficacy in recurrent affective disorders." | 3.69 | Six-year follow-up of thyroid function during lithium treatment. ( Bocchetta, A; Cherchi, A; Del Zompo, M; Derai, R; Loviselli, A; Mossa, P; Velluzzi, F, 1996) |
| "Carbamazepine (CBZ) is known to have beneficial effects in the treatment of epilepsies and in the prophylaxis of affective disorders." | 3.68 | Calcium-antagonistic effects of carbamazepine in epilepsies and affective psychoses. ( Bingmann, D; Düsing, R; Grunze, H; Liu, Z; Mayer, A; Schirrmacher, K; Walden, J, 1993) |
| "This study surveyed serum level monitoring of lithium and carbamazepine in three psychiatric hospitals, to determine how the service is used with respect to affective disorders." | 3.68 | Serum drug level monitoring in affective disorders. ( Corner, DA; Krska, J, 1992) |
| " Since the effects of carbamazepine on substance P content are identical with previously described effects of lithium, an alteration in substance P neurotransmission may be one of the neurochemical bases of common clinical and behavioral effects of carbamazepine and lithium on affective disorders." | 3.67 | Effects of chronic treatment with trihexyphenidyl and carbamazepine alone or in combination with haloperidol on substance P content in rat brain: a possible implication of substance P in affective disorders. ( Mataga, N; Mitsushio, H; Takashima, M; Toru, M, 1988) |
| "A case of thrombocytopenia associated with carbamazepine use is reported, and previous reports of adverse hematologic effects in patients taking carbamazepine are discussed." | 3.67 | Thrombocytopenia associated with carbamazepine: case report and review. ( Baciewicz, G; Yerevanian, BI, 1984) |
| "The therapeutic effects of carbamazepine (CBZ) were evaluated in 103 patients with affective disorders, 54 with schizophrenic disorders, and 26 with schizoaffective disorders by a multi-institutional open study." | 3.67 | Clinical efficacy of carbamazepine in affective, schizoaffective, and schizophrenic disorders. ( Hazama, H; Inanaga, K; Itoh, H; Kurihara, M; Okuma, T; Otsuki, S; Sarai, K; Takahashi, R; Watanabe, S; Yamashita, I, 1989) |
| "Twenty-four patients suffering from affective disorders, who were being regularly treated with carbamazepine, were studied to determine the course of plasma levels of carbamazepine before (trough levels) and two and four hours after morning intake (peak levels)." | 3.67 | Measuring plasma levels of carbamazepine. A pharmacokinetic study in patients with affective disorders. ( Broekman, M; Jansen, GS; Nolen, WA, 1988) |
| "The English-language literature indexed on MEDLINE/PubMed was searched for original observational studies (controlled and uncontrolled, prospective and retrospective), case reports, and case series that evaluated or described pharmacokinetic changes or TDM during pregnancy or the postpartum period." | 2.50 | Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring. ( Byatt, N; Deligiannidis, KM; Freeman, MP, 2014) |
| "Agents introduced for the treatment of epilepsy have also been usedsimultaneously for psychiatric indications." | 2.43 | [Anticonvulsants treatment of psychiatric disorder in elderly patients]. ( Bidzan, L, 2006) |
| "Valproic acid (VPA) is an antiepileptic drug with mood-stabilizing properties." | 2.42 | Search for a common mechanism of mood stabilizers. ( Agam, G; Harwood, AJ, 2003) |
| "Affective disorders have a substantial public health impact due to morbidity, mortality, quality of life impairment and economic implications." | 2.41 | [Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness]. ( Ahrens, B; Becker, T; Roick, C, 2001) |
| " According to the literature, OCBZ is regarded as effective in acute mania and appears to reduce the dosage of neuroleptics required for the treatment of affective and schizoaffective disorders." | 2.41 | Oxcarbazepine in affective and schizoaffective disorders. ( Dietrich, DE; Emrich, HM; Kropp, S, 2001) |
| " The newer anticonvulsants felbamate, lamotrigine, topiramate, and tiagabine have different hepatically-mediated drug-drug interactions, while the renally excreted gabapentin lacks hepatic drug-drug interactions but may have reduced bioavailability at higher doses." | 2.40 | Metabolism and excretion of mood stabilizers and new anticonvulsants. ( Corá-Locatelli, G; Frye, MA; Ketter, TA; Kimbrell, TA; Post, RM, 1999) |
| " A large number of neurotransmitters remain candidates for the psychotropic effects and a novel animal model requiring chronic administration of carbamazepine in order to show efficacy is reported (Weiss et al." | 2.38 | Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine. ( Post, RM, 1990) |
| "Carbamazepine is a tricyclic compound structurally related to imipramine that has been used since the 1960's for the treatment of trigeminal neuralgias and then approved as an anticonvulsant in the U." | 2.37 | Carbamazepine in psychiatry: a review. ( Beaudry, P; Israel, M, 1988) |
| " Because dosage in general was moderate and serum levels were within therapeutic boundaries in most cases, the symptom seemed to have been caused by an interaction of drugs rather than by a single agent." | 1.29 | Asterixis induced by psychotropic drug treatment. ( Rittmannsberger, H, 1996) |
| "Treatment with carbamazepine was evaluated in an open study design in 29 gerontopsychiatric inpatients." | 1.29 | [Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients]. ( Lemke, MR; Stuhlmann, W, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (29.17) | 18.7374 |
| 1990's | 31 (32.29) | 18.2507 |
| 2000's | 25 (26.04) | 29.6817 |
| 2010's | 11 (11.46) | 24.3611 |
| 2020's | 1 (1.04) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, AM | 1 |
| Weinshilboum, RM | 1 |
| Frye, MA | 2 |
| Biernacka, JM | 1 |
| Pariente, G | 1 |
| Leibson, T | 1 |
| Shulman, T | 1 |
| Adams-Webber, T | 1 |
| Barzilay, E | 1 |
| Nulman, I | 1 |
| Vilibić, M | 1 |
| Jukić, V | 1 |
| Vidović, A | 1 |
| Brecić, P | 1 |
| Deligiannidis, KM | 1 |
| Byatt, N | 1 |
| Freeman, MP | 1 |
| Mauer, S | 1 |
| Alahmari, R | 1 |
| Vöhringer, PA | 1 |
| Vergne, DE | 1 |
| Lövdahl, H | 1 |
| Correa, E | 1 |
| Patkar, A | 1 |
| Pae, C | 1 |
| Strejilevich, S | 1 |
| Dalley, S | 1 |
| Ghaemi, SN | 1 |
| Gorwood, P | 1 |
| Richard-Devantoy, S | 1 |
| Sentissi, O | 1 |
| Le Strat, Y | 1 |
| Olié, JP | 1 |
| Pisanu, C | 1 |
| Papadima, EM | 1 |
| Del Zompo, M | 3 |
| Squassina, A | 1 |
| Sümegi, A | 1 |
| Galbally, M | 1 |
| Roberts, M | 1 |
| Buist, A | 1 |
| Post, RM | 13 |
| Weiss, SR | 3 |
| Gazdag, G | 1 |
| Takács, R | 1 |
| Ungvari, GS | 1 |
| Tanahashi, S | 1 |
| Yamamura, S | 1 |
| Nakagawa, M | 1 |
| Motomura, E | 1 |
| Okada, M | 1 |
| Hydzik, P | 1 |
| Balicka-Slusarczyk, B | 1 |
| Jastrzebski, M | 1 |
| Brady, KT | 1 |
| Sonne, SC | 1 |
| Malcolm, RJ | 1 |
| Randall, CL | 1 |
| Dansky, BS | 1 |
| Simpson, K | 1 |
| Roberts, JS | 1 |
| Brondino, M | 1 |
| Scott, J | 1 |
| Pope, M | 1 |
| Dietrich, DE | 2 |
| Kropp, S | 2 |
| Emrich, HM | 3 |
| Harwood, AJ | 1 |
| Agam, G | 1 |
| Harris, M | 1 |
| Chandran, S | 1 |
| Chakraborty, N | 1 |
| Healy, D | 1 |
| Kaufman, KR | 1 |
| Gerner, R | 1 |
| Himmerich, H | 1 |
| Koethe, D | 1 |
| Schuld, A | 1 |
| Yassouridis, A | 1 |
| Pollmächer, T | 1 |
| Beresford, TP | 1 |
| Arciniegas, D | 1 |
| Clapp, L | 1 |
| Martin, B | 1 |
| Alfers, J | 1 |
| Selai, C | 1 |
| Bannister, D | 1 |
| Trimble, M | 1 |
| Okuma, T | 2 |
| Seifert, J | 1 |
| Metzner, C | 1 |
| Paetzold, W | 1 |
| Borsutzky, M | 1 |
| Ohlmeier, M | 1 |
| Passie, T | 1 |
| Hauser, U | 1 |
| Becker, H | 1 |
| Wiese, B | 1 |
| Emrich, H | 1 |
| Schneider, U | 1 |
| Stoner, SC | 1 |
| Lea, JW | 1 |
| Wolf, AL | 1 |
| Berges, AA | 1 |
| Staller, JA | 1 |
| Kunwar, A | 1 |
| Simionescu, M | 1 |
| Bidzan, L | 1 |
| Mazza, M | 1 |
| Della Marca, G | 1 |
| Di Nicola, M | 1 |
| Martinotti, G | 1 |
| Pozzi, G | 1 |
| Janiri, L | 1 |
| Bria, P | 1 |
| Mazza, S | 1 |
| Savica, R | 1 |
| Beghi, E | 1 |
| Mazzaglia, G | 1 |
| Innocenti, F | 1 |
| Brignoli, O | 1 |
| Cricelli, C | 1 |
| Caputi, AP | 1 |
| Musolino, R | 1 |
| Spina, E | 1 |
| Trifirò, G | 1 |
| Rajna, P | 1 |
| Ikeda, M | 1 |
| Baillieux, H | 1 |
| Verslegers, W | 1 |
| Paquier, P | 1 |
| De Deyn, PP | 1 |
| Mariën, P | 1 |
| Sheard, MH | 1 |
| Ballenger, JC | 1 |
| Uhde, TW | 3 |
| Smith, C | 1 |
| Rubinow, DR | 4 |
| Bunney, WE | 2 |
| Keisling, R | 1 |
| Altmann, H | 1 |
| Dose, M | 1 |
| von Zerssen, D | 1 |
| Jann, MW | 1 |
| Saklad, SR | 1 |
| Ereshefsky, L | 1 |
| Baciewicz, G | 1 |
| Yerevanian, BI | 1 |
| Vieweg, V | 1 |
| Pandurangi, A | 1 |
| Levenson, J | 1 |
| Silverman, J | 1 |
| De Vriese, AS | 1 |
| Philippe, J | 1 |
| Van Renterghem, DM | 1 |
| De Cuyper, CA | 1 |
| Hindryckx, PH | 1 |
| Matthys, EG | 1 |
| Louagie, A | 1 |
| Lynn, DJ | 1 |
| Fritze, J | 1 |
| Beneke, M | 1 |
| Lanczik, M | 1 |
| Schneider, B | 1 |
| Walden, J | 2 |
| Gross, R | 1 |
| Grunhaus, L | 1 |
| Lemke, MR | 1 |
| Stuhlmann, W | 1 |
| Bocchetta, A | 2 |
| Loviselli, A | 2 |
| Martino, E | 1 |
| Ketter, TA | 2 |
| Rouillon, F | 1 |
| George, MS | 1 |
| Rosenstein, D | 1 |
| Kling, MA | 1 |
| Grunze, H | 1 |
| Mayer, A | 1 |
| Düsing, R | 1 |
| Schirrmacher, K | 1 |
| Liu, Z | 1 |
| Bingmann, D | 1 |
| Gillham, R | 1 |
| Baker, G | 1 |
| Thompson, P | 1 |
| Birbeck, K | 1 |
| McGuire, A | 1 |
| Tomlinson, L | 1 |
| Eckersley, L | 1 |
| Silveira, C | 1 |
| Brown, S | 1 |
| Rittmannsberger, H | 1 |
| Cherchi, A | 1 |
| Mossa, P | 1 |
| Velluzzi, F | 1 |
| Derai, R | 1 |
| Manji, HK | 1 |
| Bebchuk, JM | 1 |
| Moore, GJ | 1 |
| Glitz, D | 1 |
| Hasanat, KA | 1 |
| Chen, G | 1 |
| Goodwin, FK | 1 |
| Baldessarini, RJ | 1 |
| Jamison, KR | 1 |
| Bowden, CL | 1 |
| Corá-Locatelli, G | 1 |
| Kimbrell, TA | 1 |
| Berner, J | 1 |
| Davis, JM | 1 |
| Janicak, PG | 1 |
| Hogan, DM | 1 |
| Iqbal, MM | 1 |
| Gundlapalli, SP | 1 |
| Ryan, WG | 1 |
| Ryals, T | 1 |
| Passman, TE | 1 |
| Goldberg, JF | 1 |
| Burdick, KE | 1 |
| Roick, C | 1 |
| Ahrens, B | 1 |
| Becker, T | 1 |
| Deckers, CL | 1 |
| Hekster, YA | 1 |
| Keyser, A | 1 |
| van Lier, HJ | 1 |
| Meinardi, H | 1 |
| Renier, WO | 1 |
| Jimerson, DC | 1 |
| Krska, J | 1 |
| Corner, DA | 1 |
| Dolan, JD | 1 |
| Kamil, R | 1 |
| Rybakowski, J | 1 |
| Terao, T | 1 |
| Friedman, DL | 1 |
| Kastner, T | 1 |
| Plummer, AT | 1 |
| Ruiz, MQ | 1 |
| Henning, D | 1 |
| Susan, R | 1 |
| Weiss, B | 1 |
| Springer, JA | 1 |
| Garvey, MJ | 1 |
| Varney, NR | 1 |
| Roberts, RJ | 1 |
| Murphy, DJ | 1 |
| Kumar, R | 1 |
| McGennis, A | 1 |
| Mitsushio, H | 1 |
| Takashima, M | 1 |
| Mataga, N | 1 |
| Toru, M | 1 |
| Motohashi, N | 1 |
| Ikawa, K | 1 |
| Kariya, T | 1 |
| Svestka, J | 1 |
| Cesková, E | 1 |
| Rysánek, R | 1 |
| Náhunek, K | 1 |
| Liu, ZZ | 1 |
| Mei, QY | 1 |
| Wan, Y | 1 |
| Lenzi, A | 1 |
| Lazzerini, F | 1 |
| Placidi, GF | 1 |
| Cassano, GB | 1 |
| Akiskal, HS | 1 |
| Yamashita, I | 1 |
| Takahashi, R | 1 |
| Itoh, H | 1 |
| Kurihara, M | 1 |
| Otsuki, S | 1 |
| Watanabe, S | 1 |
| Sarai, K | 1 |
| Hazama, H | 1 |
| Inanaga, K | 1 |
| Vieweg, WV | 2 |
| Godleski, LS | 2 |
| Evans, RW | 1 |
| Gualtieri, CT | 1 |
| Israel, M | 1 |
| Beaudry, P | 1 |
| Gold, PW | 1 |
| Nolen, WA | 1 |
| Jansen, GS | 1 |
| Broekman, M | 1 |
| Kaschka, WP | 1 |
| Thürauf, N | 1 |
| Mokrusch, T | 1 |
| Korth, M | 1 |
| Chen, CC | 1 |
| Ko, WK | 1 |
| Tirrell, C | 1 |
| DeForest, D | 1 |
| Schwarcz, G | 1 |
| Gosenfeld, L | 1 |
| Gilderman, A | 1 |
| Jiwesh, J | 1 |
| Ripple, RE | 1 |
| Signer, SF | 1 |
| Benson, DF | 1 |
| Rudnick, FD | 1 |
| Obel, AO | 1 |
| Odwako, DB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study of Prophylactic Management of Lamotrigine for Bipolar Disorder in Pregnant Women[NCT03774641] | 20 participants (Anticipated) | Observational | 2018-12-03 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
33 reviews available for carbamazepine and Affective Disorders
| Article | Year |
|---|---|
Genetics and antiepileptic mood stabilizer treatment response in bipolar disorder: what do we know?
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans; La | 2021 |
Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Infant, Newbo | 2017 |
Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.
Topics: Antidepressive Agents; Carbamazepine; Drug Monitoring; Female; Humans; Lamotrigine; Mood Disorders; | 2014 |
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: Potential involvement of epigenetics.
Topics: Antimanic Agents; Bipolar Disorder; Carbamazepine; Epigenesis, Genetic; Epigenomics; Humans; Lithium | 2018 |
[Mood stabilizers--past, present and future].
Topics: Affect; Antimanic Agents; Bipolar Disorder; Calcium; Carbamazepine; Depressive Disorder; gamma-Amino | 2008 |
Mood stabilizers in pregnancy: a systematic review.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Carbamazepin | 2010 |
Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders.
Topics: Amygdala; Animals; Anticonvulsants; Bipolar Disorder; Carbamazepine; Drug Resistance; Drug Tolerance | 2011 |
[The optimal combination of ECT with pharmacotherapy].
Topics: Affect; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tric | 2011 |
[Oxcarbazepine in the treatment of affective and schizoaffective disorders].
Topics: Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combination; Human | 2003 |
Search for a common mechanism of mood stabilizers.
Topics: Affect; Animals; Anticonvulsants; Antimanic Agents; Carbamazepine; Glycogen Synthase Kinase 3; Human | 2003 |
[Investigation on the therapeutic effect of carbamazepine on the mood disorders in Japan].
Topics: Antidepressive Agents; Carbamazepine; Double-Blind Method; Humans; Japan; Lithium; Mood Disorders | 2005 |
[Anticonvulsants treatment of psychiatric disorder in elderly patients].
Topics: Aged; Anticonvulsants; Anxiety Disorders; Bipolar Disorder; Carbamazepine; Epilepsy; Humans; Mental | 2006 |
[Effects of antiepileptic drugs on mood of people with epilepsy].
Topics: Affect; Anticonvulsants; Antidepressive Agents; Carbamazepine; Depressive Disorder; Epilepsy; Fructo | 2007 |
Effects of mood stabilizer on the circadian system: possible implication for abnormalities in mood disorders.
Topics: 5'-Nucleotidase; Animals; Antimanic Agents; Biological Clocks; Carbamazepine; Circadian Rhythm; Huma | 2007 |
Clinical pharmacology of aggressive behavior.
Topics: Adolescent; Adult; Aged; Aggression; Anger; Anti-Anxiety Agents; Benzodiazepines; Brain Chemistry; C | 1984 |
The consulting psychiatrist and the polydipsia-hyponatremia syndrome in schizophrenia.
Topics: Angiotensin II; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Carbamazepine; Cognit | 1994 |
Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature.
Topics: Adult; Aged; Carbamazepine; Drug Hypersensitivity; Epilepsy; Female; Humans; Lymphocyte Activation; | 1995 |
A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures.
Topics: Affect; Amygdala; Animals; Anticonvulsants; Bipolar Disorder; Carbamazepine; Disease Progression; Dr | 1996 |
Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Topics: Bipolar Disorder; Calcium-Calmodulin-Dependent Protein Kinases; Carbamazepine; Gene Expression; Glyc | 1999 |
Anticonvulsant therapy and suicide risk in affective disorders.
Topics: Amitriptyline; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Female; Follow | 1999 |
Metabolism and excretion of mood stabilizers and new anticonvulsants.
Topics: Anticonvulsants; Antimanic Agents; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Huma | 1999 |
Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis.
Topics: Antimanic Agents; Carbamazepine; Humans; Lithium Carbonate; Mood Disorders; Prognosis; Recurrence; S | 1999 |
Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants.
Topics: Abnormalities, Drug-Induced; Acetates; Adult; Amines; Antimanic Agents; Benzodiazepines; Breast Feed | 2001 |
Cognitive side effects of anticonvulsants.
Topics: Acetates; Amines; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cognition Disorders; Cyclohexane | 2001 |
[Prophylactic long-term therapy of affective disorders with lithium, valproic acid and carbamazepine--effectiveness and cost-effectiveness].
Topics: Antimanic Agents; Carbamazepine; Cost-Benefit Analysis; Disease Management; Germany; Humans; Lithium | 2001 |
Oxcarbazepine in affective and schizoaffective disorders.
Topics: Anticonvulsants; Carbamazepine; Humans; Mood Disorders; Oxcarbazepine; Psychotic Disorders | 2001 |
Perspectives in the treatment of the psychoneurological disorders: affective disorders.
Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans; Mood Disorders; Peptide Frag | 1979 |
Ziskind-Somerfeld Research Award 1992. Endogenous biochemical abnormalities in affective illness: therapeutic versus pathogenic.
Topics: Amygdala; Carbamazepine; Female; Humans; Kindling, Neurologic; Male; Mental Disorders; Models, Neuro | 1992 |
Mechanisms of the psychotropic action of lithium and carbamazepine.
Topics: Brain; Carbamazepine; Drug Synergism; Humans; Lithium; Mood Disorders | 1992 |
Sensitization, kindling, and carbamazepine: an update on their implications for the course of affective illness.
Topics: Animals; Behavior; Behavior, Animal; Carbamazepine; Humans; Kindling, Neurologic; Mood Disorders; Ps | 1992 |
Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine.
Topics: Carbamazepine; Humans; Kindling, Neurologic; Mood Disorders | 1990 |
Carbamazepine: a neuropsychological and psychiatric profile.
Topics: Adolescent; Adult; Attention; Blood Proteins; Carbamazepine; Child; Cognition; Epilepsy; Female; Hum | 1985 |
Carbamazepine in psychiatry: a review.
Topics: Aggression; Carbamazepine; Humans; Mental Disorders; Mood Disorders | 1988 |
11 trials available for carbamazepine and Affective Disorders
| Article | Year |
|---|---|
Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cocaine-Related Disorders; Double-Blind Method; F | 2002 |
Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Body Mass Index; Body Weight; Carbamazepine; Female; Huma | 2005 |
Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
Topics: Adult; Anticonvulsants; Buprenorphine; Carbamazepine; Diagnostic and Statistical Manual of Mental Di | 2005 |
Oxcarbazepine improves mood in patients with epilepsy.
Topics: Adult; Analysis of Variance; Anticonvulsants; Antidepressive Agents; Anxiety; Carbamazepine; Case-Co | 2007 |
Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report.
Topics: Adolescent; Adult; Analgesics; Anticonvulsants; Bipolar Disorder; Carbamazepine; Clinical Trials as | 1983 |
Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders.
Topics: Adult; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium; Male; Mood Disorders; Recu | 1994 |
Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments.
Topics: Adolescent; Adult; Affect; Aging; Anticonvulsants; Behavior; Carbamazepine; Cognition Disorders; Dou | 1996 |
Anticonvulsant therapy and suicide risk in affective disorders.
Topics: Amitriptyline; Anticonvulsants; Bipolar Disorder; Carbamazepine; Double-Blind Method; Female; Follow | 1999 |
Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cognition Disorders; Double-Blind Method; Drug Ad | 2001 |
Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders.
Topics: Aged; Aged, 80 and over; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Female; Human | 1989 |
Carbamazepine in recurrent affective disorders?
Topics: Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Humans; Mood Disorders; Recurrence | 1986 |
53 other studies available for carbamazepine and Affective Disorders
| Article | Year |
|---|---|
Cobalamin deficiency manifested with seizures, mood oscillations, psychotic features and reversible dementia in the absence of typical neurologic and hematologic signs and symptoms: a case report.
Topics: Carbamazepine; Dementia; Diazepam; Electroencephalography; Haloperidol; Hematology; Humans; Hydroxoc | 2013 |
International prescribing patterns for mood illness: the International Mood Network (IMN).
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Asia; Bipolar Disorder; Carbamazepine | 2014 |
The number of past manic episodes is the best predictor of antidepressant-emergent manic switch in a cohort of bipolar depressed patients.
Topics: Adult; Affect; Aged; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Carbamazepine; Depre | 2016 |
Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus.
Topics: Animals; Anticonvulsants; Carbamazepine; Corticotropin-Releasing Hormone; Dose-Response Relationship | 2012 |
[Cardiologic interaction carbamazepine with atypical neuroleptics. Acute mixed carbamazepine and quetiapine intoxication--case report].
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Arrhythmias, Cardiac; Bipolar Disorde | 2011 |
Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization.
Topics: Adolescent; Aged; Antimanic Agents; Biological Availability; Bipolar Disorder; Carbamazepine; Drug T | 2002 |
Mood-stabilizers: the archeology of the concept.
Topics: Affect; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Concept Formation; Forec | 2003 |
Adjunctive oxcarbazepine in comorbid anxiety and affective disorder with hyponatremic seizure: case analysis and literature review.
Topics: Adult; Anticonvulsants; Anxiety; Carbamazepine; Comorbidity; Drug Therapy, Combination; Follow-Up St | 2003 |
Reduction of affective lability and alcohol use following traumatic brain injury: a clinical pilot study of anti-convulsant medications.
Topics: Adult; Alcoholism; Anticonvulsants; Anxiety Disorders; Brain Injuries; Carbamazepine; Female; Humans | 2005 |
Antiepileptic drugs and the regulation of mood and quality of life (QOL): the evidence from epilepsy.
Topics: Affect; Anticonvulsants; Carbamazepine; Epilepsy; Health Status; Humans; Lamotrigine; Mood Disorders | 2005 |
Levetiracetam for mood stabilization and maintenance of seizure control following multiple treatment failures.
Topics: Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Female; Fructose; Humans; Levetiracetam; | 2005 |
Oxcarbazepine in the treatment of child psychiatric disorders: a retrospective chart review.
Topics: Adolescent; Anger; Antipsychotic Agents; Carbamazepine; Child; Child Behavior Disorders; Drug Admini | 2005 |
Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005.
Topics: Adolescent; Adult; Age Distribution; Aged; Amines; Anticonvulsants; Carbamazepine; Catchment Area, H | 2007 |
Cerebellar cognitive affective syndrome associated with topiramate.
Topics: Amines; Anticonvulsants; Carbamazepine; Cerebellar Diseases; Cerebellum; Cognition Disorders; Cycloh | 2008 |
Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness.
Topics: Adult; Affective Disorders, Psychotic; Aged; Bipolar Disorder; Carbamazepine; Cyclic AMP; Cyclic GMP | 1982 |
Carbamazepine and lithium carbonate in the treatment of refractory affective disorders.
Topics: Adult; Bipolar Disorder; Carbamazepine; Depressive Disorder; Humans; Lithium; Lithium Carbonate; Mal | 1983 |
Biochemical mechanisms of action of carbamazepine in affective illness and epilepsy.
Topics: Carbamazepine; Epilepsy; Humans; Mood Disorders | 1984 |
Carbamazepine for patients with affective target symptoms.
Topics: Bipolar Disorder; Carbamazepine; Female; Humans; Male; Mood Disorders | 1984 |
Thrombocytopenia associated with carbamazepine: case report and review.
Topics: Aged; Blood Cell Count; Carbamazepine; Depressive Disorder; Female; Humans; Mood Disorders; Thromboc | 1984 |
Sensitization and oscillation following repeated stimulation: relationship to affective illness and its treatment with lithium and carbamazepine [proceedings].
Topics: Animals; Carbamazepine; Humans; Lithium; Mood Disorders | 1980 |
Lithium in steroid-induced depression.
Topics: Adrenal Cortex Hormones; Adult; Carbamazepine; Female; Humans; Lithium; Mood Disorders | 1995 |
Choosing lithium, anticonvulsant, or electroconvulsant therapy for mood disorders.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic; Electroconvul | 1995 |
[Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients].
Topics: Aged; Carbamazepine; Dementia; Dose-Response Relationship, Drug; Drug Administration Schedule; Femal | 1994 |
Thyroid function during carbamazepine.
Topics: Carbamazepine; Humans; Hypothyroidism; Mood Disorders; Thyroid Function Tests; Thyroid Hormones; Thy | 1994 |
[Mood regulator agents (excluding lithium)].
Topics: Anticonvulsants; Carbamazepine; Contraindications; Humans; Mood Disorders | 1994 |
CSF magnesium in affective disorder: lack of correlation with clinical course of treatment.
Topics: Adult; Carbamazepine; Female; Humans; Lithium; Magnesium; Male; Mood Disorders; Sex Factors; Spinal | 1994 |
Calcium-antagonistic effects of carbamazepine in epilepsies and affective psychoses.
Topics: Animals; Caffeine; Calcium Channel Blockers; Carbamazepine; Epilepsy; Guinea Pigs; Hippocampus; In V | 1993 |
Asterixis induced by psychotropic drug treatment.
Topics: Adult; Aged; Carbamazepine; Clozapine; Female; Humans; Male; Middle Aged; Mood Disorders; Psychotrop | 1996 |
Six-year follow-up of thyroid function during lithium treatment.
Topics: Antibodies; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Drug Therapy, Combination; Female; | 1996 |
Effects of medical interventions on suicidal behavior. Summary and conclusions.
Topics: Anticonvulsants; Carbamazepine; Comorbidity; Depressive Disorder; Health Education; Humans; Lithium; | 1999 |
Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Humans; Li | 1999 |
Lithium-treated mood disorders, paroxysmal rhinorrhea, and mesial temporal lobe epilepsy.
Topics: Adult; Antimanic Agents; Carbamazepine; Cerebrospinal Fluid Rhinorrhea; Epilepsy, Temporal Lobe; Fem | 1999 |
Serum drug level monitoring in affective disorders.
Topics: Carbamazepine; Dose-Response Relationship, Drug; Humans; Lithium; Monitoring, Physiologic; Mood Diso | 1992 |
Atypical affective disorder with episodic dyscontrol: a case of von Economo's disease (encephalitis lethargica).
Topics: Adult; Antipsychotic Agents; Carbamazepine; Chlorpromazine; Chronic Disease; Electroencephalography; | 1992 |
Episodic dyscontrol.
Topics: Carbamazepine; Humans; Mood Disorders; Neurocognitive Disorders | 1992 |
Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Drug Therapy, Combination; Epilepsy; Female; Humans; | 1992 |
Dichotic listening failure in dysphoric neuropsychiatric patients who endorse multiple seizure-like symptoms.
Topics: Adult; Anxiety Disorders; Auditory Perception; Auditory Threshold; Carbamazepine; Depressive Disorde | 1991 |
Carbamazepine in affective disorders.
Topics: Carbamazepine; Humans; Mood Disorders | 1990 |
Effects of chronic treatment with trihexyphenidyl and carbamazepine alone or in combination with haloperidol on substance P content in rat brain: a possible implication of substance P in affective disorders.
Topics: Animals; Body Weight; Brain Chemistry; Carbamazepine; Dopamine; Dose-Response Relationship, Drug; ga | 1988 |
GABAB receptors are up-regulated by chronic treatment with lithium or carbamazepine. GABA hypothesis of affective disorders?
Topics: Animals; Baclofen; Carbamazepine; Cerebral Cortex; gamma-Aminobutyric Acid; Hippocampus; Lithium; Ma | 1989 |
Controlled cross-over comparison of carbamazepine with perphenazine in schizophrenic psychoses.
Topics: Adult; Antipsychotic Agents; Carbamazepine; Female; Humans; Male; Middle Aged; Mood Disorders; Perph | 1989 |
[A follow-up study on rapid cycling affective disorders].
Topics: Adolescent; Adult; Aged; Carbamazepine; Cyclothymic Disorder; Female; Follow-Up Studies; Humans; Lit | 1989 |
Clinical efficacy of carbamazepine in affective, schizoaffective, and schizophrenic disorders.
Topics: Adult; Carbamazepine; Female; Humans; Male; Middle Aged; Mood Disorders; Psychiatric Status Rating S | 1989 |
Polydipsia, hyponatremia, and psychosis.
Topics: Carbamazepine; Drinking; Drug Therapy, Combination; Humans; Hyponatremia; Inappropriate ADH Syndrome | 1989 |
Effect of carbamazepine on mean urinary free cortisol excretion in patients with major affective illness.
Topics: Carbamazepine; Humans; Hydrocortisone; Mood Disorders; Radioimmunoassay; Time Factors | 1986 |
Measuring plasma levels of carbamazepine. A pharmacokinetic study in patients with affective disorders.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Female; Humans; Male; Middle Aged; Mood Disorders | 1988 |
Electrooculography and dark adaptation in patients with affective and schizoaffective psychoses: early physiological effects of carbamazepine and lithium.
Topics: Adult; Aged; Aged, 80 and over; Carbamazepine; Dark Adaptation; Electrooculography; Female; Humans; | 1988 |
Carbamazepine and hyponatremia.
Topics: Carbamazepine; Drug Therapy, Combination; Humans; Hyponatremia; Lithium; Mood Disorders | 1988 |
[A clinical study on combined lithium and carbamazepine treatment of major affective disorders].
Topics: Adult; Carbamazepine; Drug Therapy, Combination; Female; Humans; Lithium; Male; Mood Disorders; Recu | 1987 |
Neuroendocrine factors in affective disorders.
Topics: Carbamazepine; Humans; Lithium; Mood Disorders; Neurosecretory Systems | 1987 |
Akathisia associated with carbamazepine therapy.
Topics: Adult; Akathisia, Drug-Induced; Carbamazepine; Humans; Male; Mood Disorders | 1986 |
Undetected affective disorder in the developmentally retarded.
Topics: Adult; Carbamazepine; Depressive Disorder; Humans; Intellectual Disability; Male; Mood Disorders | 1986 |
Practical therapeutics: the use of carbamazepine in affective disorders.
Topics: Carbamazepine; Humans; Mood Disorders | 1985 |